0001104659-24-028269.txt : 20240227
0001104659-24-028269.hdr.sgml : 20240227
20240227170022
ACCESSION NUMBER: 0001104659-24-028269
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martin Tami Tillotson
CENTRAL INDEX KEY: 0001539494
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 24688075
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm247055-24_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-23
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001539494
Martin Tami Tillotson
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
Sr. V.P., Regulatory Affairs
0
Common Stock
2024-02-23
4
A
0
1250
0
A
87418
D
Common Stock
2024-02-23
4
F
0
485
29.06
D
86933
D
Restricted Stock Unit
2024-02-23
4
D
0
1250
0
D
Common Stock
1250
3750
D
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.
/s/ Timothy C. Dec, as attorney-in-fact
2024-02-27